Cancer research is a core element of the Roswell Park mission to understand, prevent and cure cancer. As one of only 47 National Cancer Institute-designated comprehensive cancer centers, Roswell Park joins with the American Association for Cancer Research (AACR) to acknowledge May as National Cancer Research Month.
Roswell Park Clinical Research Services
At Roswell Park, we have the ability to take new cancer treatments from the “bench to the bedside.” Because we can offer some of the latest cancer therapies before they are widely available, our patients have access to more options for treating their cancer.
Why did you choose a clinical trial?
Click the images below for insight from our patients. Each poster gives a glimpse into why each person chose to participate in a clinical trial as part of his or her treatment plan at Roswell Park.
A Look Back at Highlights From Roswell Park’s Cancer Research Activities:
- Roswell Park Researchers Receive More Than $3.3 Million in Grant Support for Cancer Research Efforts
- Cleveland BioLabs, Roswell Park Announce Publication of Studies Defining Role of Liver in Activity of Entolimod (CBLB502)
- Liver Cancers Armed with Many Strategies for Evading Immune Response
- Roswell Park Scientists Advance Findings about Novel, Low-Toxicity Anticancer Agent
- Buffalo-Based Team Develops, Tests First Simulation-Based Robotic Surgery Training Curriculum
- Roswell Park Study Finds Substantial Use of E-Cigarettes by Smokers
- New Research Uncovers Promising New Biomarker for Aggressiveness of Prostate Cancer
- Investigational Brain Cancer Vaccine to Be Tested in Phase I Roswell Park Study
- Researchers at RPCI, Duke Develop Method for Pinpointing Genetic Factors That Cause Disease
- RPCI Physician is Lead Author of Phase III Study on Lenalidomide Maintenance for Myeloma Patients
Read more about cancer research conducted at RPCI and additional news items.